BERNENGO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 11.993
EU - Europa 9.224
AS - Asia 5.504
SA - Sud America 575
AF - Africa 104
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 21
Totale 27.497
Nazione #
US - Stati Uniti d'America 11.732
CN - Cina 2.727
IT - Italia 2.481
SG - Singapore 1.283
IE - Irlanda 1.073
FR - Francia 917
DE - Germania 811
SE - Svezia 698
UA - Ucraina 683
FI - Finlandia 668
KR - Corea 599
AT - Austria 468
BR - Brasile 460
GB - Regno Unito 401
PL - Polonia 339
IN - India 221
CA - Canada 216
VN - Vietnam 159
JP - Giappone 142
DK - Danimarca 115
ES - Italia 115
HK - Hong Kong 95
NL - Olanda 77
AU - Australia 69
TR - Turchia 60
CH - Svizzera 56
GR - Grecia 56
BE - Belgio 53
RU - Federazione Russa 50
SN - Senegal 50
ID - Indonesia 42
AR - Argentina 35
MX - Messico 35
CO - Colombia 32
PT - Portogallo 27
TW - Taiwan 26
RO - Romania 25
IR - Iran 22
NO - Norvegia 21
EU - Europa 20
CL - Cile 16
EG - Egitto 16
CZ - Repubblica Ceca 15
TH - Thailandia 13
HR - Croazia 12
BD - Bangladesh 11
EC - Ecuador 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
UZ - Uzbekistan 10
HU - Ungheria 9
IQ - Iraq 9
PE - Perù 9
MA - Marocco 8
RS - Serbia 8
ZA - Sudafrica 8
LB - Libano 7
LV - Lettonia 7
MU - Mauritius 7
NZ - Nuova Zelanda 7
PK - Pakistan 7
DZ - Algeria 6
MO - Macao, regione amministrativa speciale della Cina 6
VE - Venezuela 6
AL - Albania 5
BG - Bulgaria 5
JO - Giordania 5
PH - Filippine 5
SI - Slovenia 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
KW - Kuwait 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
BN - Brunei Darussalam 3
CR - Costa Rica 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
MY - Malesia 3
PA - Panama 3
QA - Qatar 3
AZ - Azerbaigian 2
EE - Estonia 2
HN - Honduras 2
LK - Sri Lanka 2
MK - Macedonia 2
NG - Nigeria 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
Totale 27.485
Città #
Beijing 2.101
Chandler 1.510
Dublin 1.067
Santa Clara 850
Singapore 603
Villeurbanne 571
Jacksonville 520
Houston 519
Princeton 455
Vienna 445
Ashburn 438
Medford 430
Ann Arbor 421
Fairfield 349
Dearborn 326
Wilmington 309
Warsaw 302
Columbus 292
Torino 292
Woodbridge 218
Milan 210
Redwood City 188
Nyköping 180
Cambridge 147
Seattle 147
Pisa 116
Boardman 107
Rome 100
Toronto 99
Pune 93
Boston 88
Dong Ket 86
Guangzhou 84
Fremont 78
Hong Kong 70
Verona 68
Shanghai 61
Helsinki 59
New York 56
Nanjing 55
Washington 52
São Paulo 51
Tokyo 48
Falls Church 47
Lachine 44
Norwalk 43
Brussels 41
Hefei 41
Turin 41
Los Angeles 35
Jakarta 32
Napoli 31
Chengdu 30
Munich 29
Athens 28
Jinan 28
Kunming 27
Des Moines 23
Florence 23
Nuremberg 23
The Dalles 22
San Diego 21
Genova 19
Madrid 19
Paris 19
Saluzzo 19
Sydney 19
Chicago 17
Hangzhou 17
Bologna 16
Buenos Aires 16
Padova 16
Santiago 16
Istanbul 15
Leiden 15
Mountain View 15
Nanchang 15
Ottawa 15
Phoenix 15
Brescia 14
London 14
Shenyang 14
Duncan 13
Newcastle Upon Tyne 13
Palermo 13
Radomsko 13
Tianjin 13
Melbourne 12
Mexico City 12
Redmond 12
Silver Spring 12
Zhengzhou 12
Zurich 12
Bogotá 11
Copenhagen 11
Rochester 11
Taipei 11
Baltimore 10
Belo Horizonte 10
Dallas 10
Totale 15.406
Nome #
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 769
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 640
Malattie bollose autoimmuni: casisitica clinica e approccio terapeutico 390
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 385
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 361
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 346
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 312
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 285
Atopic dermatitis in a phenylketonuric untreated patient 280
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus 266
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 264
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 262
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 255
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 252
Patologie dermatologie e rischio di neoplasia in pazienti portatori di trapianto di rene: revisione della casistica torinese 240
Giornale italiano di Dermatologia e Venereologia 239
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 236
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. 220
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients 219
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 216
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 207
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 203
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 195
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 193
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 188
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 180
Adult-onset cutaneous mastocytosis in monozygotic twins. 180
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 180
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 177
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 171
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 143
Prognostic differences across sexes in melanoma patients: What has changed from the past? 140
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 138
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 135
microRNA-214 promotes melanoma tumor progression 133
BANS: a discussion of the problem. 132
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 132
A retrospective analysis of the costs and management of genital warts in Italy. 127
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 126
Fotoferesi: applicazioni terapeutiche “off-label” 123
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 121
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 120
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 119
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 119
Active rosette test in cutaneous lymphoproliferative disorders. 118
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 118
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 116
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 114
Functional properties in Sézary cells with an unusual phenotype. 113
Detection of HIV p24 from antigen presenting monocytes for early diagnosis of HIV-1 infection. 112
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 110
[Activity of deoxycytidylate-deaminase in human lymphocytes stimulated with phytohemagglutinin] 109
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). 109
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 109
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 108
A case of acute promyelocytic leukaemia with bullous, haemorrhagic and necrotic skin lesions. 107
[Pemphigus-pemphigoid mixed bullous dermatosis in chronic lymphatic leukemia] 105
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 105
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 105
Multiple pyogenic granuloma of the penis. 104
Melanoma maligno della congiuntiva con infiltrazione sclerale e metastasi mediastiniche: case report 104
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 103
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 103
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 102
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 100
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 100
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 100
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 100
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 99
[Effect of methotrexate on DNA synthesis in human lymphocytes stimulated with phytohemagglutinin] 98
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 97
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 97
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 97
[Serum levels of soluble receptors of interleukin-2 in skin pathology] 96
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 96
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies. 94
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with warts. 94
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5). 93
Adhesion molecules in lymphomatoid granulomatosis 93
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 93
Micosi fungoide: dall'istopatologia alla biologia molecolare 93
Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study. 92
[Pemphigus induced by monoclonal IgM with anti-IgG antibody activity in a case of Waldenström's 's 's macroglobulinemia] 92
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 92
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphea. 92
Electrochemotherapy with intravenous bleomycin in the treatment of cutaneous and subcutaneous metastases: results of a prospective single centre trial 92
Le infezioni nella micosi fungoide e nella sindrome di Sézary 91
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. 91
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 89
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 89
Electrochemotherapy in treatment of skin melanoma metastases 89
Linfociti Treg e fotoferesi 88
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 88
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 87
The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients. 87
Leucosis and skin: acute lymphoid immunoblastic leukaemia. 87
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. 87
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 87
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 86
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 86
Totale 15.625
Categoria #
all - tutte 82.372
article - articoli 0
book - libri 0
conference - conferenze 28.660
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020423 0 0 0 0 0 0 0 0 0 0 220 203
2020/20212.424 393 137 186 137 204 157 182 93 254 232 191 258
2021/20222.499 63 92 138 135 150 106 161 123 86 131 484 830
2022/20234.440 621 274 105 351 492 1.110 388 265 445 78 209 102
2023/20241.764 231 293 124 98 119 244 68 67 18 83 126 293
2024/20253.943 68 351 152 434 1.267 227 156 263 634 316 75 0
Totale 28.445